Deep Track Capital, LP Chinook Therapeutics, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$17.51 - $23.37 $7.53 Million - $10.1 Million	-430,110 Reduced 12.54%	3,000,000 $59 Million
Q2 2022 Aug 12, 2022	BUY	$12.59 - $18.8 $5.42 Million - $8.09 Million	430,110 Added 14.34%	3,430,110 $60 Million
Q1 2022 May 16, 2022	BUY	$12.02 - $16.69 $6.97 Million - $9.67 Million	579,498 Added 23.94%	3,000,000 $49.1 Million
Q4 2021 Feb 14, 2022	BUY	$10.69 - $16.83 $25.9 Million - $40.7 Million	2,420,502 New	2,420,502 $39.5 Million

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.